I submitted a rapid response letter to an excellent study in the BMJ, which looked at industry payments to journal editors. I provided further data for pathology journal editors.

Pathologists are an indispensable part of patient care and advancing biomedical science. The data show that the pharmaceutical and medical device industries are keenly aware of this. Despite some other specialties receiving a greater amount of industry payments, I hope we do not succumb to glib relativism by downplaying any conflict of interest. Pathologists should self-monitor our profession to ensure these potential financial conflicts do not interfere with clinical practice in matters of test purchasing, selection or interpretation, as well as in scientific endeavors.

You can read my letter at BMJ.com.